Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 13/20 | 0.53 |
| ▸ | FURIN | P09958 | 1/20 | 0.51 |
| ▸ | HRH1 | P35367 | 1/20 | 0.49 |
| ▸ | CTSD | P07339 | 1/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29720238 | 0.96 | BACE1 (0.57) | BACE1FURINCTSD | |
| SCHEMBL30686814 | 0.93 | BACE1 (0.53) | BACE1HRH1CTSD | |
| SCHEMBL30019046 | 0.91 | BACE1 (0.64) | BACE1CTSD | |
| SCHEMBL29720348 | 0.89 | BACE1 (0.60) | BACE1CTSD | |
| SCHEMBL30120725 | 0.88 | BACE1 (0.55) | BACE1CTSDNAALAD2 | |
| SCHEMBL31603949 | 0.87 | BACE1 (0.64) | BACE1CTSD | |
| SCHEMBL30769684 | 0.87 | TFPI (0.57) | BACE1FURINHRH1 | |
| SCHEMBL31730257 | 0.87 | BACE1 (0.61) | BACE1CTSD | |
| SCHEMBL31462936 | 0.86 | NPY4R (0.54) | FURIN | |
| SCHEMBL29373145 | 0.85 | SLC15A2 (0.49) | FURIN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4326330-A1 | GLUCAGON LIKE PEPTIDE COMPOUNDS | Novartis AG (CH) | 2024-02-28 | — | — | EP | claimed |
| WO-2022224164-A1 | GLUCAGON LIKE PEPTIDE COMPOUNDS | NOVARTIS AG (CH) | 2022-10-27 | — | — | WO | claimed |
| EP-4380962-A1 | PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | MSN Laboratories Private Limited, R&D Center (IN) | 2024-06-12 | — | — | EP | disclosed |
| EP-4326330-A1 | GLUCAGON LIKE PEPTIDE COMPOUNDS | Novartis AG (CH) | 2024-02-28 | — | — | EP | disclosed |
| WO-2023012829-A1 | PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2023-02-09 | — | — | WO | disclosed |
| WO-2022224164-A1 | GLUCAGON LIKE PEPTIDE COMPOUNDS | NOVARTIS AG (CH) | 2022-10-27 | — | — | WO | disclosed |